Evaluation of the Hologic Aptima Combo 2 Assay for Detection of Neisseria gonorrhoeae from Joint Fluid Specimens
- PMID: 35317619
- PMCID: PMC9020330
- DOI: 10.1128/jcm.02530-21
Evaluation of the Hologic Aptima Combo 2 Assay for Detection of Neisseria gonorrhoeae from Joint Fluid Specimens
Abstract
Gonorrhea is a sexually transmitted bacterial infection caused by Neisseria gonorrhoeae. Nucleic acid amplification testing is the preferred method for routine diagnosis of gonorrhea from urogenital specimens, but culture is commonly used for diagnosis of disseminated infections, including gonococcal arthritis. The Hologic Aptima Combo 2 (AC2), a transcription-mediated amplification assay, is FDA and Health Canada licensed for detection of N. gonorrhoeae and Chlamydia trachomatis from urogenital, rectal, and pharyngeal specimens, but not joint fluid. In the current study, we compared the performance of microscopy, culture, and the AC2 for detection of N. gonorrhoeae from 170 joint fluid specimens. A total of five specimens were culture-positive, whereas 14 were AC2-positive. Gram-negative diplococci, characteristic of Neisseria, were observed in only two joint fluid specimens. Complementary testing confirmed the presence of N. gonorrhoeae in seven discordant (i.e., culture-negative/AC2-positive) specimens. These results indicate that the AC2 is more sensitive than culture for the diagnosis of gonococcal arthritis.
Keywords: Neisseria gonorrhoeae; disseminated gonococcal infection; nucleic acid amplification testing.
Conflict of interest statement
The authors declare a conflict of interest. David C. Alexander has received nonfinancial support to explore the development of assays on the Hologic Fusion system.
Similar articles
-
Evaluation of self-collected glans and rectal swabs from men who have sex with men for detection of Chlamydia trachomatis and Neisseria gonorrhoeae by use of nucleic acid amplification tests.J Clin Microbiol. 2009 Jun;47(6):1657-62. doi: 10.1128/JCM.02269-08. Epub 2009 Apr 15. J Clin Microbiol. 2009. PMID: 19369445 Free PMC article.
-
No widespread dissemination of Chlamydia trachomatis diagnostic-escape variants and the impact of Neisseria gonorrhoeae positivity on the Aptima Combo 2 assay.Sex Transm Infect. 2022 Aug;98(5):366-370. doi: 10.1136/sextrans-2021-054988. Epub 2021 Sep 11. Sex Transm Infect. 2022. PMID: 34510008
-
Sensitivity, specificity, inclusivity and exclusivity of the updated Aptima Combo 2 assay, which provides detection coverage of the new diagnostic-escape Chlamydia trachomatis variants.BMC Infect Dis. 2020 Jun 16;20(1):419. doi: 10.1186/s12879-020-05148-7. BMC Infect Dis. 2020. PMID: 32546213 Free PMC article.
-
Diagnostic Tests for Detecting Chlamydia trachomatis and Neisseria gonorrhoeae in Rectal and Pharyngeal Specimens.J Clin Microbiol. 2022 Apr 20;60(4):e0021121. doi: 10.1128/JCM.00211-21. Epub 2021 Nov 3. J Clin Microbiol. 2022. PMID: 34731021 Free PMC article. Review.
-
[The infections by Chlamydia trachomatis and Neisseria gonorrhoeae].Rinsho Byori. 2002 Nov;Suppl 123:57-61. Rinsho Byori. 2002. PMID: 12652791 Review. Japanese.
References
-
- Chan PA, Robinette A, Montgomery M, Almonte A, Cu-Uvin S, Lonks JR, Chapin KC, Kojic EM, Hardy EJ. 2016. Extragenital infections caused by Chlamydia trachomatis and Neisseria gonorrhoeae: a review of the literature. Infect Dis Obstet Gynecol 2016:5758387. doi:10.1155/2016/5758387. - DOI - PMC - PubMed
-
- Mayor MT, Roett MA, Uduhiri KA. 2012. Diagnosis and management of gonococcal infections. Am Fam Physician 86:931–938. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical